FindTrial
Sign In

Vaccine effectiveness in COVID-19

Vaccine effectiveness in Covid-19 patients against severe infections and death in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037962
Enrollment
1000
Registered
2021-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Surag MK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted with covid RT-PCR test positive

Exclusion criteria

Exclusion criteria: A primary diagnosis other than Covid pneumonia

Design outcomes

Primary

MeasureTime frame
DeathTimepoint: 4 weeks—

Secondary

MeasureTime frame
Severe infectionTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Surag MK

Government Medical College Kannur Pariyaram

suragsreedhar@gmail.com9400480660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026